More about

Cabergoline

News
April 18, 2024
10 min read
Save

New consensus statement addresses advances in diagnosing, managing prolactinomas

The way endocrinologists manage prolactinomas is changing.

News
May 21, 2023
1 min read
Save

Cabergoline effective for preventing breast symptoms after abortion, pregnancy loss

BALTIMORE — A one-time dose of off-label cabergoline after second-trimester abortion or pregnancy loss was effective for preventing symptomatic breast engorgement, according to data presented at the ACOG Annual Clinical & Scientific Meeting.

News
November 15, 2019
2 min read
Save

Cabergoline may increase recurrence risk after remission in Cushing’s disease

Use of the dopamine agonist cabergoline during conventional fractionated radiotherapy to treat Cushing’s disease may be associated with a higher disease recurrence rate after an initial remission, according to findings published in Clinical Endocrinology.